Pakistan Wire News
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Dutch Bros, Inc. (NYSE: BROS) between March 1, 2022 and May 11, 2022, both dates inclusive (the “Class Period”), of the important May 1, 2023 lead plaintiff deadline. SO WHAT: If you […]
Islamabad, March 28, 2023 (PPI-OT): The National Assembly Tuesday passed a resolution calling for simultaneous elections for all the assemblies under impartial and caretaker setups in a free and fair manner to achieve goal of real political stability in the…
Islamabad, March 28, 2023 (PPI-OT): Prime Minister Shehbaz Sharif has said the government is committed to prioritizing the development of the merged districts. He was talking to a five-member delegation of the National Assembly members from the merged districts that…
Islamabad, March 28, 2023 (PPI-OT): The National Assembly discussed a motion on the political and constitutional crisis in the country. Participating in the debate, speakers called for supremacy of law and independence of the judiciary in the country. Taking the…
Islamabad, March 28, 2023 (PPI-OT): Foreign Secretary Asad Majeed Khan has reiterated Pakistan’s desire for a peaceful, prosperous, stable and connected Afghanistan. He was talking to Germany’s Representative for Afghanistan, Ambassador Erik Kurzweil who called on him in Islamabad Tuesday….
Islamabad, March 28, 2023 (PPI-OT): Pakistan and Malaysia have agreed to further expand and strengthen bilateral strategic partnership and enhance multi-dimensional cooperation. An understanding to this effect came at bilateral political consultations held in Kuala Lumpur on Tuesday. The talks…
Islamabad, March 28, 2023 (PPI-OT): The United States has urged all sides in Pakistan to respect the rule of law and allow the people to democratically determine their country’s leadership in accordance with the constitution and law. Replying a question…
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Sarepta […]